Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY), BLOOD CANCER UNITED FKA THE LEUKEMIA & LYMPHOMA SOCIETY, BLOOD CANCER UNITED, BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
Client-Reported Lobbying Expenses
$13.4M
109 filings
Firm Income Reported for This Client
$370K
Not substituted for client expenses
Summary
BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) is an organization, based in DC. Its political footprint includes $13.4 million in client-reported lobbying expenses, $370K in lobbying-firm income reported for this client. Lobbying activity focuses on Health Issues, Budget/Appropriations, Medicare/Medicaid, Medical/Disease Research/Clinical Labs. Political activity spans from 2001 to 2026.
These are different money flows and are not added together: contributions and lobbying expenses flow out, while contract awards flow to the organization.
Lobbying Spend Trend
↑ 92% YoY
2025: $1.9M (complete years)
Activity data: Senate LDA